Nonrulemaking

Patent Term Application for COBENFY (xanomeline tartrate and trospium chloride), Patent No. 10,369,144

🏛 Food and Drug Administration (FDA)FDA-2025-E-0154

Pharmaceutical Policy

Documents

1

Total comments

0

all analyzed

Comment status

Open

Last activity

—

In this docket

Documents

Rules, notices, and supporting material — the primary rule pinned first.

Notice· Feb 6, 2026
Determination of Regulatory Review Period for Purposes of Patent Extension; COBENFY→
Closed on Aug 6, 2026